Overview
Acute respiratory distress syndrome (ARDS) is a severe, life-threatening form of respiratory failure caused by widespread inflammatory injury to the lungs, in which fluid accumulates in the alveoli and impairs gas exchange, producing profound hypoxaemia. It can be precipitated by direct insults such as pneumonia and aspiration or by indirect causes including sepsis, trauma and systemic inflammation, and is characterised by the rapid onset of breathlessness, diffuse pulmonary infiltrates and reduced lung compliance. ARDS frequently requires intensive care and mechanical ventilation, and despite supportive management it carries a high risk of organ failure and death. The syndrome attracted renewed attention during the COVID-19 pandemic, when severe SARS-CoV-2 infection emerged as a prominent cause of acute lung injury. Research published in this journal reflects this clinical context, including evaluation of whether the alveolar-arterial oxygen pressure difference can aid diagnosis of ARDS in pneumonia patients, and numerous studies of COVID-19 spanning narrative reviews, cytokine profiling in hospitalised patients, candidate therapies, and post-infectious complications. Additional work considers profiles of patients dying in respiratory-medicine settings and cardiorespiratory monitoring. Together these studies illustrate ongoing interest in the diagnosis, pathophysiology, inflammatory mechanisms and management of acute respiratory failure, particularly in the setting of severe viral and bacterial pneumonia.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The Novel Coronavirus 2019 (COVID-19): A Narrative Review
Random Forest Classifier for Respiratory Mortality Analytics
Cytokine Profiling in COVID-19 Patients in a Tertiary Hospital in Saudi Arabia; the Pre-Storm Phase
Cell Therapy as an Alternative approach for COVID-19 Infection Consequences: A Non-Systematic Review
Animals in the COVID-19 Era: Between Being a source, Victims, or Maybe our Hope to Overcome it!
Effect of Hydroxychloroquine on Clinical Improvement and Mortality Among Patients with COVID-19 Admitted to Four General Hospitals in Saudi Arabia
Chirps Amidst Coronavirus Disease-2019 (COVID-19) Transmission and Prevention in Ethiopia in 2020
Post-Covid-19 Acute Disseminated Encephalomyelitis (ADEM) in a 27-year-old girl: Case Report
Profile of Patients Who Died During One Year in the Pneumophthisiology Department of the Hospital National Ignace Deen CHU in Conakry
Evaluation of cardiorespiratory parameters in dogs undergoing laparoscopic versus open gonadectomy with spontaneous ventilation anaesthesia: a pilot study
Redefining Coronavirus: Update on the Impacts of COVID-19 in the Rural Areas of Abia State
How this research is being cited
The 12 articles above have been cited 12 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Nov 2026.
-
2025 · Jundishapur Journal of Microbiology
-
2025 · Jundishapur Journal of Microbiology
-
2025 · Inflammopharmacology
-
2025 · Inflammopharmacology
-
2022 · Scholars Journal of Medical Case Reports
-
Tristan Merlin et al. · 2022 · Journal of the American Veterinary Medical Association
-
Cell Therapy as an Alternative approach for COVID-19 Infection Consequences: A Non-Systematic Review2021 · International Journal of Coronaviruses
-
Cell Therapy as an Alternative approach for COVID-19 Infection Consequences: A Non-Systematic Review2021 · International Journal of Coronaviruses
A sample of recent works citing this journal's research on Acute Respiratory Distress Syndrome, linking to each citing work.